Autologous Adipose-derived Stem cells
Sponsors
Adistem Ltd, Celltex Therapeutics Corporation
Conditions
COVID-19Type 1 Diabetes MellitusType 2 Diabetes Mellitus
Phase 1
Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Patients With Type 1 Diabetes
NCT00703599
Start: 2007-11-30End: 2009-12-31Target: 30Updated: 2008-07-01
Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Type 2 Diabetics
NCT00703612
Start: 2007-11-30End: 2009-01-31Updated: 2008-07-01